Concepts (71)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gaucher Disease | 1 | 2022 | 12 | 0.800 |
Why?
|
| Spinal Cord Compression | 1 | 2022 | 30 | 0.760 |
Why?
|
| Sarcoma, Ewing | 1 | 2022 | 111 | 0.730 |
Why?
|
| Anemia, Hypochromic | 1 | 2021 | 7 | 0.720 |
Why?
|
| Mentoring | 1 | 2021 | 79 | 0.640 |
Why?
|
| Military Personnel | 1 | 2021 | 196 | 0.600 |
Why?
|
| Anemia, Sickle Cell | 1 | 2022 | 333 | 0.580 |
Why?
|
| Bone Neoplasms | 1 | 2022 | 430 | 0.570 |
Why?
|
| Etoposide | 2 | 2022 | 117 | 0.350 |
Why?
|
| Enzyme Therapy | 1 | 2022 | 5 | 0.200 |
Why?
|
| Ifosfamide | 1 | 2022 | 32 | 0.200 |
Why?
|
| Anti-Bacterial Agents | 3 | 2024 | 2406 | 0.200 |
Why?
|
| Vincristine | 1 | 2022 | 193 | 0.190 |
Why?
|
| Fever | 1 | 2024 | 299 | 0.180 |
Why?
|
| Embolism, Air | 1 | 2001 | 24 | 0.180 |
Why?
|
| Doxorubicin | 1 | 2022 | 290 | 0.180 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2001 | 130 | 0.170 |
Why?
|
| Cyclophosphamide | 1 | 2022 | 414 | 0.170 |
Why?
|
| Spinal Cord | 1 | 2022 | 307 | 0.170 |
Why?
|
| Catheterization, Central Venous | 1 | 2001 | 130 | 0.170 |
Why?
|
| Leukopenia | 1 | 2000 | 47 | 0.160 |
Why?
|
| Schools, Medical | 1 | 2021 | 115 | 0.160 |
Why?
|
| Nonprescription Drugs | 1 | 2000 | 48 | 0.160 |
Why?
|
| Escherichia coli Infections | 1 | 2001 | 183 | 0.160 |
Why?
|
| Zinc | 1 | 2000 | 136 | 0.160 |
Why?
|
| Mentors | 1 | 2021 | 153 | 0.160 |
Why?
|
| Pulmonary Embolism | 1 | 2001 | 176 | 0.150 |
Why?
|
| Neutropenia | 1 | 2000 | 197 | 0.150 |
Why?
|
| Drug Hypersensitivity | 1 | 2019 | 100 | 0.150 |
Why?
|
| Wilms Tumor | 1 | 2019 | 117 | 0.140 |
Why?
|
| Ventricular Function, Left | 1 | 2001 | 520 | 0.140 |
Why?
|
| Desensitization, Immunologic | 1 | 2019 | 106 | 0.140 |
Why?
|
| Personal Satisfaction | 1 | 2018 | 103 | 0.140 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2001 | 794 | 0.140 |
Why?
|
| Bacteremia | 1 | 2001 | 401 | 0.140 |
Why?
|
| Neoplasms | 2 | 2024 | 2807 | 0.130 |
Why?
|
| Hodgkin Disease | 1 | 2019 | 292 | 0.130 |
Why?
|
| Heart | 1 | 2001 | 736 | 0.130 |
Why?
|
| Anemia | 1 | 2000 | 344 | 0.130 |
Why?
|
| Students, Medical | 1 | 2021 | 356 | 0.130 |
Why?
|
| Cost-Benefit Analysis | 1 | 2018 | 517 | 0.130 |
Why?
|
| Disease Progression | 1 | 2022 | 2103 | 0.120 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2022 | 1262 | 0.120 |
Why?
|
| Health Care Costs | 1 | 2018 | 376 | 0.120 |
Why?
|
| Ambulatory Care | 1 | 2018 | 397 | 0.120 |
Why?
|
| Neuroblastoma | 1 | 2019 | 530 | 0.110 |
Why?
|
| Humans | 10 | 2024 | 126330 | 0.110 |
Why?
|
| Adolescent | 5 | 2024 | 19548 | 0.110 |
Why?
|
| Child | 5 | 2024 | 24766 | 0.090 |
Why?
|
| Antineoplastic Agents | 1 | 2019 | 1725 | 0.080 |
Why?
|
| Female | 5 | 2024 | 67333 | 0.060 |
Why?
|
| Time-to-Treatment | 1 | 2024 | 190 | 0.050 |
Why?
|
| Home Nursing | 1 | 2001 | 16 | 0.050 |
Why?
|
| Child, Preschool | 3 | 2024 | 14221 | 0.050 |
Why?
|
| Self Medication | 1 | 2000 | 22 | 0.040 |
Why?
|
| Acne Vulgaris | 1 | 2000 | 20 | 0.040 |
Why?
|
| Blood Cell Count | 1 | 2000 | 70 | 0.040 |
Why?
|
| Copper | 1 | 2000 | 65 | 0.040 |
Why?
|
| Infusions, Intravenous | 1 | 2001 | 554 | 0.040 |
Why?
|
| Radiography | 1 | 2001 | 805 | 0.040 |
Why?
|
| Febrile Neutropenia | 1 | 2018 | 13 | 0.040 |
Why?
|
| Clinical Protocols | 1 | 2019 | 240 | 0.040 |
Why?
|
| Allergens | 1 | 2019 | 257 | 0.030 |
Why?
|
| Echocardiography | 1 | 2001 | 1075 | 0.030 |
Why?
|
| Male | 4 | 2024 | 62031 | 0.030 |
Why?
|
| Disease Management | 1 | 2018 | 529 | 0.030 |
Why?
|
| Health Personnel | 1 | 2018 | 513 | 0.030 |
Why?
|
| Parents | 1 | 2018 | 1028 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2019 | 4874 | 0.020 |
Why?
|
| Middle Aged | 1 | 2018 | 27031 | 0.010 |
Why?
|
| Adult | 1 | 2018 | 29802 | 0.010 |
Why?
|